Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Palvella Therapeutics, Inc. (PVLA) had Normalized Income after Taxes of $-15.77M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-15.77M |
|
-- |
|
-- |
|
$14.86M |
|
$-14.86M |
|
$-0.91M |
|
$-15.77M |
|
$-15.77M |
|
$-15.77M |
|
$-15.77M |
|
$-15.77M |
|
|
Normalized Income after Taxes |
$-15.77M |
$-14.86M |
|
$-14.86M |
|
13.09M |
|
13.09M |
|
$-1.20 |
|
$-1.20 |
|
| Balance Sheet Financials | |
$263.23M |
|
-- |
|
$0.53M |
|
$263.76M |
|
$9.12M |
|
-- |
|
$22.33M |
|
$31.45M |
|
$232.31M |
|
$232.31M |
|
$232.31M |
|
14.31M |
|
| Cash Flow Statement Financials | |
$-10.86M |
|
$-55.44M |
|
$214.73M |
|
$57.98M |
|
$206.39M |
|
$148.41M |
|
$3.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
28.88 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.86M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.79% |
|
-6.79% |
|
-5.98% |
|
-6.79% |
|
$16.23 |
|
$-0.83 |
|
$-0.83 |
|